CHLORHYDRATE D'OXYBUPROCAINE THEA 1.6 mg/0.4 ml, eye drops in a single-dose container 20 single-dose containers of 0.4 ml
Active ingredients: Benoxinate hydrochloride
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Eye drops20 single-dose containers of 0.4 mlophtalmique
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- CHLORHYDRATE D'OXYBUPROCAINE THEA 1,6 mg/0,4 ml, collyre en récipient unidose
- Pharmaceutical form
- collyre
- Route of administration
- ophtalmique
- Presentation description
- 20 récipient(s) unidose(s) polyéthylène de 0,4 ml
- Marketing authorisation holder
- THEA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Nov 2005
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- For professional use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68503549CIP73657686CIP133400936576865Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'OXYBUPROCAÏNEcollyre | 1,6 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.